日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Incidence and prevalence of immune-mediated extraintestinal manifestations in pediatric inflammatory bowel disease: a systematic review and meta-analysis

儿童炎症性肠病免疫介导肠外表现的发生率和患病率:系统评价和荟萃分析

Boden, Elisa K; Canavan, James B; Moran, Christopher J; McCann, Katelyn; Dunn, William A; Farraye, Francis A; Ananthakrishnan, Ashwin N; Yajnik, Vijay; Gandhi, Roopali; Nguyen, Deanna D; Bhan, Atul K; Weiner, Howard L; Korzenik, Joshua R; Snapper, Scott B; Schnell, Alexander; Wei, Xinyi; Bossenz, Jan; Manuilova, Iryna; Christoph, Jan; Allabauer, Ida; Classen, Merle; Regensburger, Adrian P; Woelfle, Joachim; Erber, Ramona; Hoerning, André; Almasry, Mazen; Schell, Trevor L; Richard, Luke; Farraye, Francis A; Hayney, Mary S; Caldera, Freddy; Reinisch, Walter; Peyrin-Biroulet, Laurent; D’Haens, Geert; Sturm, Andreas; Anderson, Jaclyn K; Messina, Izabella; Arikan, Dilek; Zimmerman-Bennett, Alissa; Parmentier, Julie; Feng, Tian; D’Cunha, Ronilda; Lazar, Andreas; Louis, Edouard; Colman, Ruben J; Vuyyuru, Sudheer K; Solitano, Virginia; MacDonald, John K; Le, Jessica; Ricciuto, Amanda; Berard, Roberta; Mohammed, Javed A; Ma, Christopher; Jairath, Vipul; Crowley, Eileen

Influenza vaccine uptake among patients with inflammatory bowel disease: comparable outcomes between telemedicine and in-person care

炎症性肠病患者流感疫苗接种率:远程医疗与面对面就诊的效果相当

Almasry, Mazen; Schell, Trevor L; Richard, Luke; Farraye, Francis A; Hayney, Mary S; Caldera, Freddy

Bezlotoxumab for prevention of Clostridioides difficile recurrence in patients with inflammatory bowel disease: a retrospective multicenter experience

贝洛妥珠单抗预防炎症性肠病患者艰难梭菌复发:一项回顾性多中心研究

Karime, Christian; Odah, Tarek; Hashash, Jana G; Pardi, Darrell S; Khanna, Sahil; Farraye, Francis A

MUC1 as a biomarker in primary sclerosing cholangitis and cholangiocarcinoma

MUC1作为原发性硬化性胆管炎和胆管癌的生物标志物

Hashash, Jana G; Beatty, Pamela; Yan, Irene K; Nakhleh, Raouf; Camilleri, Micheal; Harnois, Denise; Farraye, Francis A; Francis, Fadi F

Gaps in the diagnosis of small bowel adenocarcinoma among patients with Crohn's disease: a tertiary care perspective

克罗恩病患者小肠腺癌诊断的不足:三级医疗机构的视角

Zayat, Marisa-Nicole S; Griend, Micah Vander; Hashash, Jana G; Kinnucan, Jami; Picco, Michael; Farraye, Francis A; Siu, Rex K

The mouth as a window: A multi-center retrospective study of oral extraintestinal manifestations of IBD and their management

口腔是窗口:一项关于炎症性肠病口腔肠外表现及其治疗的多中心回顾性研究

Aristizabal-Torres, M-A; Janovska, M; Loeb, L-P; Ma, Y; Rogers-Iii, R-S; Farraye, F-A; Bruce, A-J; Chedid, V; Hashash, J-G; Bodiford, K-J

The Gut Microbiome as a Biomarker and Therapeutic Target of Immune Checkpoint Inhibitors: A Review for Oncologists

肠道微生物组作为免疫检查点抑制剂的生物标志物和治疗靶点:肿瘤科医生的综述

Susiriwatananont, Thiti; Eiamprapaporn, Panuch; Vazquez Roque, Maria; Farraye, Francis A; Perlman, Adam; Chumsri, Saranya

Patients With Inflammatory Bowel Disease Are at Increased Risk of Respiratory Syncytial Virus Infections After Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Propensity-Matched Cohort Analysis

炎症性肠病患者在严重急性呼吸综合征冠状病毒2感染后发生呼吸道合胞病毒感染的风险增加:一项倾向性匹配队列分析

Alsakarneh, Saqr; Ramirez Ramirez, Oscar; Hayney, Mary S; Hashash, Jana G; Farraye, Francis A; Caldera, Freddy

Immunogenicity and Safety of Recombinant Herpes Zoster Vaccine in Patients With Inflammatory Bowel Disease on Vedolizumab or Anti-Tumor Necrosis Factor Therapy

重组带状疱疹疫苗在接受维多珠单抗或抗肿瘤坏死因子治疗的炎症性肠病患者中的免疫原性和安全性

Caldera, Freddy; Mogallapalli, Harshitha; Abusalim, Abdul-Rahman; Farraye, Francis A; Hayney, Mary S

Accelerating Earlier Access to Anti-TNF-α Agents with Biosimilar Medicines in the Management of Inflammatory Bowel Disease

利用生物类似药加速早期获得抗TNF-α药物治疗炎症性肠病

Fiorino, Gionata; Ananthakrishnan, Ashwin; Cohen, Russell D; Cross, Raymond K; Deepak, Parakkal; Farraye, Francis A; Halfvarson, Jonas; Steinhart, A Hillary